Literature DB >> 31679729

Cystic fibrosis bone disease: Pathophysiology, assessment and prognostic implications.

Abeer Anabtawi1, Trang Le2, Melissa Putman3, Vin Tangpricha4, Maria Luisa Bianchi5.   

Abstract

Cystic fibrosis bone disease (CFBD) is a common long-term complication of cystic fibrosis (CF) that can lead to increased fractures and significant morbidity and mortality in this patient population. CFBD pathophysiology remains poorly understood and is likely to be multifactorial. There are limited studies evaluating diagnostic tools and tests to guide therapeutic decisions and monitoring of CFBD. This review will present and discuss the current evidence.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone turn over markers; Cystic fibrosis; Cystic fibrosis bone disease; DXA

Year:  2019        PMID： 31679729     DOI： 10.1016/j.jcf.2019.08.018

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


  9 in total

1.  Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis.

Authors:  HuiChuan J Lai; Lyanne H Chin; Sangita Murali; Taiya Bach; Danielle Sander; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2022-01-20

2.  Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients.

Authors:  Karin Yaacoby-Bianu; Zeev Schnapp; Ilana Koren; Anat Ilivitzki; Mohamed Khatib; Nadeem Shorbaji; Michal Shteinberg; Galit Livnat
Journal:  BMC Pharmacol Toxicol       Date:  2022-10-20       Impact factor: 2.605

3.  Relationship Between Estrogen Treatment and Skeletal Health in Women With Cystic Fibrosis.

Authors:  Malinda Wu; Erika L Bettermann; Neha Arora; William R Hunt; Courtney McCracken; Vin Tangpricha
Journal:  Am J Med Sci       Date:  2020-06-06       Impact factor: 2.378

4.  Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density.

Authors:  Malinda Wu; William R Hunt; Melissa S Putman; Vin Tangpricha
Journal:  J Clin Transl Endocrinol       Date:  2020-03-19

5.  Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients.

Authors:  Axelle Schmoll; Claire Launois; Jeanne-Marie Perotin; Bruno Ravoninjatovo; Muriel Griffon; Sophie Carré; Pauline Mulette; Julien Ancel; Jean Hagenburg; François Lebargy; Gaëtan Deslée; Jean-Hugues Salmon; Sandra Dury
Journal:  Front Med (Lausanne)       Date:  2022-02-08

6.  An update on methods for assessing bone quality and health in Cystic fibrosis.

Authors:  Kristen M Williams; Amy Darukhanavala; Rebecca Hicks; Andrea Kelly
Journal:  J Clin Transl Endocrinol       Date:  2021-12-06

7.  Bone accrual and structural changes over one year in youth with cystic fibrosis.

Authors:  Rosara M Bass; Babette S Zemel; Virginia A Stallings; Mary B Leonard; Jaime Tsao; Andrea Kelly
Journal:  J Clin Transl Endocrinol       Date:  2022-03-25

8.  Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors.

Authors:  Julien Ancel; Claire Launois; Jeanne-Marie Perotin; Bruno Ravoninjatovo; Pauline Mulette; Jean Hagenburg; Julie Malet; Muriel Griffon; Sophie Carré; François Lebargy; Gaëtan Deslée; Sandra Dury
Journal:  Healthcare (Basel)       Date:  2022-07-21

Review 9.  Update on the management of vitamins and minerals in cystic fibrosis.

Authors:  Senthilkumar Sankararaman; Sara J Hendrix; Terri Schindler
Journal:  Nutr Clin Pract       Date:  2022-08-23       Impact factor: 3.204
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.